Leading medical organizations team up to bring new TB treatments to those in need
03/19/2015. International organizations Partners In Health (PIH), Médecins Sans Frontières (MSF), Interactive Research and Development (IRD) and their financial partner UNITAID will start in April the endTB project, a partnership aimed at radically changing the management of multidrug-resistant tuberculosis (MDR-TB).
By 2019, endTB will provide access to two new anti-TB drugs (bedaquiline and delamanid), for 2,600 MDR-TB patients in 16 countries. These are the first new anti-TB drugs developed in over 50 years and these drugs offer new hope to patients suffering from MDR-TB.
Read the article on MSF website
Related Articles
In front of the expanding of Daech in Libya and the Sahel risks destabilizing the answer can only be military
02/21/2016. We face the risk of explosion from an area where currently live about 100 million inhabitants
The French National Humanitarian Conference
02/23/2016. What will be the role of international humanitarian actors in the aid system of the future?
8 things we must do to tackle humanitarian crises in 2019
01/31/2019. Today, a colossal 120 million people globally need aid just to survive as a result of violence and conflict.
